08-Apr-2008 - A rapid microbial detection kit presented as the only genetic-based test on the market to quantify yeast and mould has been launched by Switzerland's Lonza.
07-Apr-2008 - US-based engineering services firm Emerson announced at Interphex that it has been selected to digitally automate a new facility in China that will produce the country's first monoclonal antibody (mAb) drugs.
07-Apr-2008 - GlaxoSmithKline (GSK) has scored a decisive victory in its efforts to head off new US patent rules that would strike at the heart of the way the drug industry goes about protecting its inventions.
03-Apr-2008 - The use of disposable manufacturing equipment in pharmaceutical production and greater need for containment equipment were recurring themes at the Interphex show in Philadelphia last week, and both were addressed by new equipment from Bosch Packaging Technology.
02-Apr-2008 - Pall seems to have shaken off the financial turmoil of recent months in the second quarter of 2008, with a 15 per cent hike in sales to $626m helped by favourable dollar exchange rates and a strong performance by its biopharmaceuticals division.
02-Apr-2008 - With manufacturing productivity in the pharmaceutical sector widely acknowledged as being in need of modernisation, a US firm believes it has developed a technology that could carve days off the time spent on microbial testing, a cumbersome but ubiquitous part of the quality control process.
01-Apr-2008 - Gore PharmBio chose this year's Interphex trade show to showcase two new products to assist biomanufacturers.
01-Apr-2008 - Sterile process engineering consultancy firm Isogen is taking a maiden voyage into the manufacturing side of drugs with the construction of its first facility, aimed to fill a gap in small-scale injectables.
27-Mar-2008 - The ageing population of the European Union (EU) could result in a stagnation in technological innovation, according to a new report. As science and technology professionals get older and less socially mobile, there are fears that it could result in a loss in scientific expertise.
27-Mar-2008 - Research and development investment by America's pharmaceutical and biotechnology research companies reached a record $58.8bn last year, a rise of $3bn since 2006.
26-Mar-2008 - The generic pharmaceutical industry has given short shrift to the latest congressional attempt to construct a viable approval pathway for biosimilars in the US.
26-Mar-2008 - The pharmaceutical industry has lost confidence in the UK as a place to do business to an "alarming degree" and the situation is only set to deteriorate, reveals new research.
25-Mar-2008 - The International Society for Pharmaceutical Engineering (ISPE) is offering a "unique training experience" for pharmaceutical professionals through a partnership with North Carolina State University in the US.
06-Mar-2008 - A new user and environmentally-friendly fume hood claimed to cut emissions as well as operating and energy costs has been launched at Pittcon 2008.
20-Feb-2008 - Generic drug manufacturer Vintage Pharmaceuticals has fallen foul of the regulatory authorities in the US once again for failing to meet quality standards.
14-Feb-2008 - Questions are hanging over the role of a Chinese manufacturing facility in the Baxter heparin scare after it has emerged that the US Food and Drug Administration (FDA) has never inspected the facility.
13-Feb-2008 - Pfizer's announcement of plans to create a new €130m inhaled medicines unit at its facility in Amboise, France suggests that the firm is still intent on investing in inhalation technology, despite its disappointment with Exubera.
07-Feb-2008 - Germany put in a strong showing as category winners were announced for the fourth annual Facility of the Year Awards (FOYA) recognising innovation in pharmaceutical manufacturing projects.
06-Feb-2008 - Cellexus Biosystems, the UK company that designs, manufactures and sells disposable cell growth technology for the biopharmaceutical industry, is extending the rental plan offered on its CellMaker Lite2 single-use bioreactor in response to significant demand since the plan was introduced last September.
04-Feb-2008 - Novartis has been given a warning by US regulators detailing significant failures in its investigation into tracking down the source of contamination in some of its vaccines.
07-Dec-2007 - UK-based William Ransom & Son has been advised to voluntarily recall certain products following a false contamination scare at its Witham, Essex, facility.
05-Dec-2007 - The combination products market is zooming ahead, requiring the need to address regulatory challenges, an author of a white paper says.
23-Nov-2007 - The official report into good manufacturing practice (GMP) failures that caused dangerous contamination and a Europe-wide recall of Roche's HIV drug Viracept (nelfinavir) claims the firm simply did not understand its own manufacturing processes.
30-Oct-2007 - Two pharmaceutical companies have faced explosions at their plants in the last week, local media reported.
02-Oct-2007 - The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials.